Management of Severely Elevated INR

Initial Assessment and Management

For patients with INR >9 without bleeding, the American College of Cardiology recommends withholding warfarin therapy completely, administering vitamin K1 2.5-5 mg orally, and monitoring INR within 24 hours to ensure it's decreasing appropriately 1, 2
For patients with INR >9 with active bleeding, hospital admission is required, and administration of vitamin K 5-10 mg by slow IV infusion, as well as consideration of prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP) administration, is recommended 1

When INR exceeds 5, the risk of hemorrhage greatly increases, according to the American Heart Association 3

For patients with mechanical heart valves, the American College of Cardiology recommends using caution with vitamin K administration to avoid valve thrombosis if INR falls too rapidly, and lower doses of vitamin K (1.0-2.0 mg) may be more appropriate for these patients 1, 2
Bridging anticoagulation with either intravenous unfractionated heparin or subcutaneous low-molecular-weight heparin is recommended during the time interval when the INR is subtherapeutic in patients with mechanical heart valves, as suggested by the American Heart Association 3

The American College of Cardiology recommends investigating the cause of elevated INR, such as drug interactions, dietary changes, or illness, and adjusting maintenance dose of warfarin if necessary, as well as increasing frequency of INR monitoring until stability is achieved 1, 2

Administering vitamin K intravenously when not necessary can lead to anaphylactic reactions, and oral administration is preferred when possible, according to the American College of Cardiology 1
High-dose vitamin K should not be given routinely to patients with mechanical heart valves, as this may create a hypercoagulable condition, as warned by the American Heart Association 3